Figure 1From: The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemiaThe overall survival of acute myeloid leukemia (AML) patients after treatment with all-trans retinoic acid (ATRA), valproic acid and low-dose cytarabine. The figure presents a comparison of responder and nonresponder patients according to the MDS criteria [19]. The mean survival is indicated for each group.Back to article page